Building upon these reports, we therefore hypothesized an alternative potential interference strategy: addressing the WNT–FZD signaling axis directly on the receptor level through a FZD-targeting molecule such as compound 11 should also reduce the viability of RNF43-negative and thus WNT-sensitive pancreatic cancer cells. The gene discussed is RNF43; the disease is familial pancreatic carcinoma.